MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3324/haematol.2010.039768

Медицинская библиотека · Haematologica · 2011

Array-based genomic screening at diagnosis and during follow-up in chronic lymphocytic leukemia.

Gunnarsson Rebeqa, Mansouri Larry, Isaksson Anders, Göransson Hanna, Cahill Nicola, Jansson Mattias, Rasmussen Markus, Lundin Jeanette, Norin Stefan, Buhl Anne Mette, Smedby Karin Ekström, Hjalgrim Henrik, Karlsson Karin, Jurlander Jesper, Geisler Christian, Juliusson Gunnar, Rosenquist Richard

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

High-resolution genomic microarrays enable simultaneous detection of copy-number aberrations such as the known recurrent aberrations in chronic lymphocytic leukemia [del(11q), del(13q), del(17p) and trisomy 12], and copy-number neutral loss of heterozygosity. Moreover, comparison of genomic profiles from sequential patients' samples allows detection of clonal evolution.

DESIGN AND

METHODS

We screened samples from 369 patients with newly diagnosed chronic lymphocytic leukemia from a population-based cohort using 250K single nucleotide polymorphism-arrays. Clonal evolution was evaluated in 59 follow-up samples obtained after 5-9 years.

RESULTS

At diagnosis, copy-number aberrations were identified in 90% of patients; 70% carried known recurrent alterations, including del(13q) (55%), trisomy 12 (10.5%), del(11q) (10%), and del(17p) (4%). Additional recurrent aberrations were detected on chromosomes 2 (1.9%), 4 (1.4%), 8 (1.6%) and 14 (1.6%). Thirteen patients (3.5%) displayed recurrent copy-number neutral loss of heterozygosity on 13q, of whom 11 had concurrent homozygous del(13q). Genomic complexity and large 13q deletions correlated with inferior outcome, while the former was linked to poor-prognostic aberrations. In the follow-up study, clonal evolution developed in 8/24 (33%) patients with unmutated IGHV, and in 4/25 (16%) IGHV-mutated and treated patients. In contrast, untreated patients with mutated IGHV (n=10) did not acquire additional aberrations. The most common secondary event, del(13q), was detected in 6/12 (50%) of all patients with acquired alterations. Interestingly, aberrations on, for example, chromosome 6q, 8p, 9p and 10q developed exclusively in patients with unmutated IGHV.

CONCLUSIONS

Whole-genome screening revealed a high frequency of genomic aberrations in newly diagnosed chronic lymphocytic leukemia. Clonal evolution was associated with other markers of aggressive disease and commonly included the known recurrent aberrations.

Для цитирования: Gunnarsson Rebeqa, Mansouri Larry, Isaksson Anders, Göransson Hanna, Cahill Nicola, Jansson Mattias, Rasmussen Markus, Lundin Jeanette, Norin Stefan, Buhl Anne Mette, Smedby Karin Ekström, Hjalgrim Henrik, Karlsson Karin, Jurlander Jesper, Geisler Christian, Juliusson Gunnar, Rosenquist Richard. Array-based genomic screening at diagnosis and during follow-up in chronic lymphocytic leukemia.. Haematologica. 2011. DOI: 10.3324/haematol.2010.039768.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.